CD8A and neoplasm: The stimulatory capacity of these exosomes on HLA-A2-restricted, CD8+ T cell clones or oligoclonal cell lines derived from tumour infiltrating lymphocytes and displaying known antigen-specificity was tested by IFNγ ELISpot, cytokine release assay and flow cytometry.